ClinicalTrials.Veeva

Menu

Efficacy and Safety of Posterior Scleral Reinforcement on Controlling Myopia in Adults With High Myopia

Capital Medical University logo

Capital Medical University

Status and phase

Unknown
Phase 2

Conditions

Axial Elongation
Myopia Progression
Adults
High Myopia
Posterior Scleral Reinforcement

Treatments

Procedure: Posterior scleral reinforcement

Study type

Interventional

Funder types

Other

Identifiers

NCT03381079
TRECKY2017-049

Details and patient eligibility

About

This study will evaluate the efficacy and safety of posterior scleral reinforcement on controlling myopia progression, including change in refraction, axial elongation as well as sight-threatening complications, in adults with high myopia. Half the adults will receive posterior scleral reinforcement, while the other half will receive no surgerical treatment.

Enrollment

120 estimated patients

Sex

All

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Cycloplegic spherical equivalent less than -6.0 D
  • Myopia progression greater than 1.0 D per year
  • Normal IOP, no strabismus or any other ocular pathological changes
  • no any other ocular or systematic diseases that may affect refractive development

Exclusion criteria

  • Currently or history using other interventions to control myopia progression (acupuncture, drugs, contact lens, ear needles and so on)
  • Unable to cooperate with the ocular examination,questionnaire survey,or orthokeratology wearing

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

120 participants in 2 patient groups

Surgical group
Experimental group
Description:
In this arm, the adults with high myopia will be given posterior scleral reinforcement.
Treatment:
Procedure: Posterior scleral reinforcement
Control group
No Intervention group
Description:
In this arm, the adults with high myopia will not be given any surgical treatment.

Trial contacts and locations

0

Loading...

Central trial contact

Shi-Ming Li, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems